Jason Vinyard

Vice President Of Global Business Development at NorthStar Medical Radioisotopes, LLC

Jason Vinyard has extensive work experience in the pharmaceutical and medical industry. Jason currently holds the position of VP, Business Development Advanced Radioisotopes & Therapeutic Technologies at NorthStar Medical Radioisotopes, LLC since July 2021. Prior to this role, they worked at Curium Pharma from 2015 to 2021, where they served as the Director of Global Sales and Business Development and later as the Area Business Director. From 2005 to 2015, Jason worked at Mallinckrodt Pharmaceuticals, where they held various positions including Director of Strategic Accounts, Regional Sales Manager, and Senior Account Manager. Jason started their career at Regional Nuclear Pharmaceuticals as a Facility Manager from 2000 to 2005, where they successfully transformed the company into a profitable organization and implemented effective sales strategies. Jason Vinyard has demonstrated skills in business development, pharmaceutical sales, and nuclear medicine throughout their career. Jason has received several awards for their outstanding performance and has been elected to Mallinckrodt's Sales Leadership Council.

Jason Vinyard's education history includes a Master of Business Administration (M.B.A.) in Business Administration and Management, General, from the University of St. Francis, which they obtained from 2009 to 2011. Prior to that, they pursued a Masters in Health Care Administration, specializing in Health/Health Care Administration/Management, from the same university, from 2005 to 2007. In 1997 to 2000, Jason attended Jacksonville State University, where they studied Forensic Science. Additionally, they completed an Associate of Arts (A.A.) degree in Criminal Justice/Law Enforcement Administration at Jefferson State Community College, from 1995 to 1996.

Location

Birmingham, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


NorthStar Medical Radioisotopes, LLC

NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.


Employees

201-500

Links